Cliff Asness's EXAS Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 2.23 M shares of Exact Sciences Corporation (EXAS) worth $226.41 M, representing 0.12% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 45 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in EXAS, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2025, adding 741,517 shares. Largest reduction occurred in Q3 2013, reducing 576,000 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Exact Sciences Corporation (EXAS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Exact Sciences Corporation (EXAS) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +412,183 | Add 22.68% | 2.23 M | $101.56 |
| Q3 2025 | +63,894 | Add 3.64% | 1.82 M | $53.65 |
| Q2 2025 | +741,517 | Add 73.29% | 1.75 M | $53.14 |
| Q1 2025 | +419,381 | Add 70.80% | 1.01 M | $43.14 |
| Q4 2024 | +337,727 | Add 132.62% | 592,385 | $56.19 |
| Q3 2024 | +101,060 | Add 65.80% | 254,658 | $66.55 |
| Q2 2024 | -399,558 | Reduce 72.23% | 153,598 | $42.25 |
| Q1 2024 | -88,271 | Reduce 13.76% | 553,156 | $69.06 |
| Q4 2023 | +313,110 | Add 95.37% | 641,427 | $73.98 |
| Q3 2023 | +207,623 | Add 172.02% | 328,317 | $68.22 |
| Q2 2023 | +115,346 | Add 2156.81% | 120,694 | $93.90 |
| Q1 2023 | +5,348 | New Buy | 5,348 | $66.50 |
| Q4 2021 | -4,007 | Sold Out | 0 | $0.00 |
| Q2 2021 | -9,666 | Reduce 70.69% | 4,007 | $124.28 |
| Q1 2021 | +2,198 | Add 19.15% | 13,673 | $128.36 |
| Q4 2020 | +7,965 | Add 226.92% | 11,475 | $132.46 |
| Q3 2020 | -1,706 | Reduce 32.71% | 3,510 | $101.71 |
| Q2 2020 | -9,193 | Reduce 63.80% | 5,216 | $85.51 |
| Q1 2020 | -1,559 | Reduce 9.76% | 14,409 | $58.02 |
| Q4 2019 | -8,492 | Reduce 34.72% | 15,968 | $92.31 |
| Q3 2019 | +728 | Add 3.07% | 24,460 | $90.35 |
| Q2 2019 | -37,274 | Reduce 61.10% | 23,732 | $118.03 |
| Q1 2019 | +45,118 | Add 283.98% | 61,006 | $86.61 |
| Q4 2018 | -11,725 | Reduce 42.46% | 15,888 | $63.13 |
| Q3 2018 | -28,224 | Reduce 50.55% | 27,613 | $78.91 |
| Q2 2018 | -149,906 | Reduce 72.86% | 55,837 | $59.78 |
| Q1 2018 | +6,406 | Add 3.21% | 205,743 | $40.33 |
| Q4 2017 | -14,216 | Reduce 6.66% | 199,337 | $52.54 |
| Q3 2017 | -6,269 | Reduce 2.85% | 213,553 | $47.12 |
| Q2 2017 | +711 | Add 0.32% | 219,822 | $35.37 |
| Q1 2017 | +86,315 | Add 65.00% | 219,111 | $23.62 |
| Q4 2016 | +2,760 | Add 2.12% | 132,796 | $13.36 |
| Q3 2016 | +130,036 | New Buy | 130,036 | $18.56 |
| Q4 2015 | -49,356 | Sold Out | 0 | $0.00 |
| Q3 2015 | -20,493 | Reduce 29.34% | 49,356 | $17.99 |
| Q2 2015 | +4,042 | Add 6.14% | 69,849 | $29.74 |
| Q4 2014 | +22,700 | Add 52.66% | 65,807 | $27.44 |
| Q3 2014 | +43,107 | New Buy | 43,107 | $19.37 |
| Q4 2013 | -11,607 | Sold Out | 0 | $0.00 |
| Q3 2013 | -576,000 | Reduce 98.02% | 11,607 | $11.80 |
| Q2 2013 | +587,607 | Add 0.00% | 587,607 | $13.91 |
| Q4 2012 | +64,707 | Add 0.00% | 64,707 | $10.59 |
Cliff Asness's Exact Sciences Corporation Investment FAQs
Cliff Asness first purchased Exact Sciences Corporation (EXAS) in Q4 2012, acquiring 64,707 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Exact Sciences Corporation (EXAS) for 45 quarters since Q4 2012.
Cliff Asness's largest addition to Exact Sciences Corporation (EXAS) was in Q2 2025, adding 1,753,283 shares worth $93.17 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 2,229,360 shares of Exact Sciences Corporation (EXAS), valued at approximately $226.41 M.
As of the Q4 2025 filing, Exact Sciences Corporation (EXAS) represents approximately 0.12% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Exact Sciences Corporation (EXAS) was 2,229,360 shares, as reported at the end of Q4 2025.